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No reliable anatomical or functional alterations have been confirmed in psychiatric neuroimaging; however it can
become reliable with translational impact on clinical practice when considering crucial methodological issues. We
provide guidelines to authors, editors and reviewers in the implementation/evaluation of neuroimaging studies to
bend neuroimaging to be more than basic neuroscience.
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Meta-analysesBackground
More than three decades after Johnstone’s first compu-
terised axial tomography of the brain of individuals with
schizophrenia [1], no consistent or reliable anatomical
or functional alterations have been univocally associated
with any mental disorder and no neurobiological altera-
tions have been ultimately confirmed in psychiatric
neuroimaging.
A number of methodological problems may underlie
the inconsistencies across studies and the difficulty of
identifying reliable results. Heterogeneity in psychiatric
neuroimaging originates from multiple differences across
studies: in conceptual issues underlying psychiatric diag-
noses and psychopathology [2,3], the inclusion criteria
for and the clinical characteristics of psychiatric samples
[4]; the use of different paradigms and designs [4], and
the use of different forms of image acquisition and
image analysis [5].Discussion
The latter point is critically addressed by the recent
study of Ioannidis [6]. He stated that “the excess signifi-
cance may be due to unpublished negative results, or it
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distribution, and reproduction in any mediumpositive results through selective exploratory analyses”
[6]. Because of multiple comparisons across different
brain regions, reporting of regions of interest (ROIs) can
be guided by post-hoc significance of the results, with
the whole brain results remaining unpublished [6]. Add-
itionally, when there are many ROI analyses that can be
performed, only one of them, the one with the best
results, may be presented [6]. These practices limit the
correct localization of the potential brain abnormalities,
which should be based on a whole-brain analysis of the
differences between patients and controls. To make an
analogy, it’s as if an attorney decides to investigate only
an arbitrary subgroup of the suspects of a crime, and
not to report any proof, which may involve individuals
which he wants to keep untarnished.
As Ioannidis acknowledged these concerns do mainly
refer to morphometry studies and not directly extend to
automated whole-brain voxel-based studies or functional
imaging studies. In particular, voxel-based meta-analyses
have the potential to overcome the limited sample size
of individual studies revealing structural differences at
specific brain coordinates rather than differences in
volumes of pre-specified ROIs. A recently developed
meta-analytic method, Signed Differential Mapping [7,8],
considers null findings as well and thus attenuates the
disproportionate influence of single study data sets.
However, even meta-analyses of voxel-based studies are
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noted that no meta-analytic method can detect an ab-
normality if this is deliberately not reported in the indi-
vidual studies, e.g. by repeating the analysis with
different parameters until the finding disappears. This
may be the case of abnormalities in regions not thought
to be related to the disorder, which may be “felt” to be
false positives or artifacts [8] by the authors of the stud-
ies and by the peer-reviewers.
Conclusions and practical guidelines for authors,
editors and reviewers
Only by overcoming these biases, the results of psychi-
atric neuroimaging can become more reliable and have a
translational impact on clinical practice. The study by
Ioannidis represents a milestone in psychiatric imaging,
pointing to crucial methodological issues at the level of
imaging analysis. Although the Ioannidis study makes
general recommendations, this manuscript tries to for-
mulate a checklist of practical guidelines for authors,
editors and reviewers that are easy to implement and
follow. This may help to ultimately bend psychiatric
neuroimaging to be something more than basic
neuroscience:
i. With an increasing number of ways of preprocessing
the data becoming available, this should be described
in enough detail by the authors to allow exact
replication;
ii. ROI studies (employing preselected masks or
adopting Small Volume Corrections) should first
report standard whole brain results and acknowledge
if no significant clusters were detected at whole brain
level before presenting the ROI findings;
iii. Both ROIs and whole brain studies should first
report the results significant at p < 0.05 corrected for
multiple comparisons (i.e. FWE, FDR, Montecarlo)
and then employ more liberal thresholds;
iv. When several ROIs are used, correction for multiple
comparisons should be based on a mask which
includes all of them rather than considering each
ROI separately;
v. Authors should be encouraged to blind the statistical
analyses of the imaging datasets to avoid ROI
analyses be built post-hoc on the basis of the results;
vi. All studies should report a statistical analysis
modelling an agreed set of possible confounding
variables; these could include, for instance, gender,
age and handedness. In addition, studies would havethe option of reporting further statistical analyses
modelling additional study-specific confounding
variables;
vii. All studies should acknowledge the number of
analyses or brain correlations performed, giving a
clear rationale for each, to avoid conducting
exploratory analyses and reporting the most
significant result;
viii. The potential overlapping of the patient and control
group with previously published studies should be
clearly acknowledged, and the spatial coordinates
always reported, to assist future voxel-based meta-
analyses in the field;
ix. Peer-reviews should be as strict when assessing the
methods of a study reporting abnormalities in
expected brain regions, as when assessing the
methods of a study not finding any expectable
finding;
x. Acceptance or rejection of a manuscript should not
depend on whether abnormalities are detected or
not, nor on the specific brain regions found to be
abnormal.
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